These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17038643)

  • 21. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
    Leipner C; Grün K; Borchers M; Stelzner A
    Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
    Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
    Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway.
    Shi Y; Fukuoka M; Li G; Liu Y; Chen M; Konviser M; Chen X; Opavsky MA; Liu PP
    Circulation; 2010 Jun; 121(24):2624-34. PubMed ID: 20530002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
    Huber SA
    Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo.
    Loudon RP; Moraska AF; Huber SA; Schwimmbeck P; Schultheiss P
    J Virol; 1991 Nov; 65(11):5813-9. PubMed ID: 1656071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
    He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
    Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased susceptibility of male BALB/c mice to coxsackievirus B3-induced myocarditis: role for CD1d.
    Huber SA
    Med Microbiol Immunol; 2005 May; 194(3):121-7. PubMed ID: 15107990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
    Huber S; Song WC; Sartini D
    Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.
    Henke A; Huber S; Stelzner A; Whitton JL
    J Virol; 1995 Nov; 69(11):6720-8. PubMed ID: 7474082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
    Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
    Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-37 Ameliorates Coxsackievirus B3-induced Viral Myocarditis by Modulating the Th17/Regulatory T cell Immune Response.
    An B; Liu X; Li G; Yuan H
    J Cardiovasc Pharmacol; 2017 May; 69(5):305-313. PubMed ID: 28207428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIF is a critical survival factor in viral cardiomyopathy.
    Riad A; Westermann D; Zietsch C; Savvatis K; Becher PM; Bereswill S; Heimesaat MM; Lettau O; Lassner D; Dörner A; Poller W; Busch M; Felix SB; Schultheiss HP; Tschöpe C
    J Immunol; 2011 Feb; 186(4):2561-70. PubMed ID: 21239721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis.
    Liu W; Dienz O; Roberts B; Moussawi M; Rincon M; Huber SA
    Exp Mol Pathol; 2012 Jun; 92(3):327-33. PubMed ID: 22465422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coxsackievirus B3-induced chronic myocarditis in mouse: use of whole blood culture to study the activation of TNF alpha-producing cells.
    Hober D; Andreoletti L; Shen L; Copin MC; Desmidt A; Wattré P
    Microbiol Immunol; 1996; 40(11):837-45. PubMed ID: 8985939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3.
    Seko Y; Takahashi N; Yagita H; Okumura K; Yazaki Y
    J Pathol; 1997 Sep; 183(1):105-8. PubMed ID: 9370955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis.
    Huber SA; Stone JE; Wagner DH; Kupperman J; Pfeiffer L; David C; O'Brien RL; Davis GS; Newell MK
    J Virol; 1999 Jul; 73(7):5630-6. PubMed ID: 10364312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.